Long-term Oral Baclofen Treatment in a Child With Cerebral Palsy: Electroencephalographic Changes and Clinical Adverse Effects

Abstract

Baclofen is widely used to control spasticity in children with cerebral palsy. Several publications described clinical adverse effects of baclofen oral treatment, but the effect of baclofen on seizure potentiation is still controversial. We describe a 10-year-old female patient with cerebral palsy, epilepsy, and mental retardation who developed clinical adverse effects (confusion, agitated state, insomnia, diffuse hypotonia, and hyporeflexia) and electroencephalographic (EEG) changes (quasiperiodic, generalized burst of sharp waves that take up >50% of standard EEG) during long-term oral baclofen treatment, after gradually increasing the dosage but still within the therapeutic dose. Our case showed clearly that the EEG changes in our patient, with a history of epilepsy in good control, have been induced by the baclofen increase, and we describe the possible mechanisms that could explain proconvulsive effect of baclofen.

Keywords

baclofen cerebral palsy seizure

Get full access to this article

View all access options for this article.

References

Butler C. , Campbell S. Evidence of the effects of intrathecal baclofen for spastic and dystonic cerebral palsy: AACPDM treatment outcomes committee review panel. Dev Med Child Neurol. 2000;42(9):634-645.

Young RR , Delwaide PJ Drug therapy: spasticity (second of two parts). N Engl J Med . 1981;304:96-99.

Muller H. , Zierski J. , Dralle D. , et al. Pharmacokinetics of intrathecal baclofen. In: Muller H , Zierski J , Penn R , eds. Local-Spinal Therapy of Spasticity . Berlin: Springer-Verlag. 1988:223-226.

Jamous A. , Kennedy P. , Psychol C. , et al. Psychological and emotional effects of the use of oral baclofen: a preliminary study. Paraplegia. 1994;32(5):349-353.

Sandyk R. , Gillman MA Baclofen-induced memory impairment. Clin Neuropharmacol. 1985;8(3):294-295.

Young RR , Emre M. , Nance PW Current issues in spasticity management. Neurologist. 1997;3:261-275.

Terrence CF , Fromm GH , Roussan MF Baclofen: its effect on seizure frequency. Arch Neurol. 1983;40(1):28-29.

Perry HE , Wright RO , Shannon MW , et al. Baclofen overdose: drug experimentation in a group of adolescent . Pediatrics. 1998;101:1045-1048.

Rush JM , Gibberd FB Baclofen induced-epilepsy. J R Soc Med. 1990 ;83:115-116.

10.

Zak R. , Solomon G. , Petito F. , et al. Baclofen induced generalized nonconvulsive status epilepticus . Ann Neurol. 1994;36: 113-114.

11.

Kofler M. , Kronenberg MF , Rifici C. , et al. Epileptic seizures associated with intrethecal baclofen application . Neurology. 1994;44: 25-27.

12.

Fakhoury T. , Abou-Khalil B. , Blumenkopf B. EEG changes in intrathecal baclofen overdose: a case report and review of the literature. Electroencephalogr Clin Neurophysiol. 1998;107(5): 339-342.

13.

Degan PH , Reiss W. The determination of γ-amino-β-(P-chlorophenyl) butyric acid (baclofen) in biological material by gas-liquid chromatography. J Chromatogr . 1972;117:399.

14.

Brodgen RN , Speight TM , Avery GS Baclofen: a preliminary report of its pharmacological properties and therapeutic efficacy in spasticity. Drugs. 1974;8:1-14.

15.

Alsen ML , Dietz MA , Rossi P. , et al. Clinical and pharmacokinetic aspects of high dose oral baclofen therapy. J Am Paraplegia Soc. 1992;15(4):211-216.

16.

Hansel DE , Hansel CR , Shindle MK , et al. Oral baclofen in cerebral palsy: possible seizure potentation ? Pediatr Neurol. 2003; 29(3):203-206.

17.

Zafeirious DI , Kontopoulos EE , Tsikoulas I. Characteristics and prognosis of epilepsy in children with cerebral palsy. J Child Neurol. 1999;14:289-294.